Author

F.M. de Man

Observed names: F. De Man, de Man, F

Institutions: Erasmus MC, Erasmus MC Cancer Institute

Observed institutions: Erasmus MC, Erasmus MC Cancer Institute

OpenAlex ID: A5016738508

Drug-Drug Interactions in Patients Treated for Cancer: a Prospective Study on Clinical Interventions

2014 · R.W. van Leeuwen, F.G.A. Jansman, et al. · Annals of Oncology · 2

412P Phase I study of intraperitoneal irinotecan in combination with standard systemic chemotherapy in patients with extensive peritoneal metastases of colorectal origin: The INTERACT trial

2022 · R.A.G. Van Eerden, N.L. De Boer, et al. · Annals of Oncology · 1

805P Toxicity outcomes of patients who received UGT1A1 genotype-guided irinotecan dosing: A multicentre real-world study

2025 · S.L.J. Peeters, N. Heersche, et al. · Annals of Oncology

2238P Survival outcomes after UGT1A1 genotype-guided dosing of irinotecan: Results of a multicentre survival analysis

2025 · N. Heersche, S.L.J. Peeters, et al. · Annals of Oncology

Works count: 5

Citation count: 3

H-index: 1

I10-index: